Literature DB >> 12467066

Loss of adhesion-regulated proteinase production is correlated with invasive activity in oral squamous cell carcinoma.

Supurna Ghosh1, Hidayatullah G Munshi, Ratna Sen, Laura A Linz-McGillem, Robert D Goldman, Jochen Lorch, Kathleen J Green, Jonathan C R Jones, M Sharon Stack.   

Abstract

BACKGROUND: Oral squamous cell carcinoma (OSCC) is the most common malignancy of the oral cavity. However, the cellular and biochemical factors that underlie locoregional and distant spread of the disease are poorly understood. Invasion of OSCC requires multiple cellular events including dissolution of cell-cell junctions, basement membrane attachment, extracellular matrix proteolysis, and migration.
METHODS: We evaluated these properties in vitro using premalignant gingival keratinocytes (ppl26) and two OSCC lines (SCC15 and SCC68). Expression of adhesion molecules integrins and cadherins, cytoplasmic intermediate filaments (IF) vimentin and keratin as well as matrix degrading proteins were evaluated. Moreover, regulation of protease production by adhesion molecules was tested.
RESULTS: All cell lines contained comparable levels of the epithelial cell-cell adhesion molecule, E-cadherin. Differential expression of cytoplasmic IF was evident between premalignant pp126 cells and OSCC cell lines. Expression levels of the alpha3beta1 integrin, utilized for attachment to laminin-5 and other matrix proteins, was high in SCC68 cells, moderate in SCC15 cells, and low in ppl26 cells. alpha3beta1 integrin clustering up-regulates expression of urinary-type plasminogen activator (uPA) in ppl26 cells via a mechanism involving ERK activation. Both ppl26 and SCC15 cells were responsive to alpha3beta1 clustering, resulting in enhanced uPA expression. However, basal uPA levels were high in SCC68 cells and integrin clustering did not further stimulate uPA production. ERK was constitutively activated in SCC68 cells and treatment of cells with an inhibitor of ERK activation (PD98059) reduced uPA expression. Consistent with the enhanced proteolytic potential, SCC68 cells readily penetrated Matrigel and invasion was blocked by an anticatalytic uPA antibody.
CONCLUSIONS: These data suggest that loss of adhesion-regulated proteinase production may lead to elevated pericellular proteinase activity and coincident alterations in cytoskeletal IF protein expression, thereby contributing to the invasive potential of OSCC. Copyright 2002 American Cancer Society.DOI 10.1002/cncr.10997

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12467066     DOI: 10.1002/cncr.10997

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Urinary-type plasminogen activator receptor (uPAR) modulates oral cancer cell behavior with alteration in p130cas.

Authors:  Zonggao Shi; Yueying Liu; Jeffrey J Johnson; M Sharon Stack
Journal:  Mol Cell Biochem       Date:  2011-06-01       Impact factor: 3.396

2.  Cell-surface expression of a mutated Epstein-Barr virus glycoprotein B allows fusion independent of other viral proteins.

Authors:  Marisa P McShane; Richard Longnecker
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-06       Impact factor: 11.205

3.  Polypyrimidine tract-binding protein (PTB) differentially affects malignancy in a cell line-dependent manner.

Authors:  Chen Wang; John T Norton; Supurna Ghosh; Julie Kim; Kazuo Fushimi; Jane Y Wu; M Sharon Stack; Sui Huang
Journal:  J Biol Chem       Date:  2008-05-22       Impact factor: 5.157

4.  MicroRNA-184 antagonizes microRNA-205 to maintain SHIP2 levels in epithelia.

Authors:  Jia Yu; David G Ryan; Spiro Getsios; Michelle Oliveira-Fernandes; Anees Fatima; Robert M Lavker
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-25       Impact factor: 11.205

5.  EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression.

Authors:  Géraldine Lescaille; Suzanne Menashi; Bénédicte Cavelier-Balloy; Farah Khayati; Cathy Quemener; Marie Pierre Podgorniak; Benyoussef Naïmi; Fabien Calvo; Céleste Lebbe; Samia Mourah
Journal:  BMC Cancer       Date:  2012-03-23       Impact factor: 4.430

6.  Prognostic value analysis of urokinase-type plasminogen activator receptor in oral squamous cell carcinoma: an immunohistochemical study.

Authors:  Roberta Bacchiocchi; Corrado Rubini; Elisa Pierpaoli; Giulia Borghetti; Pasquale Procacci; Pier Francesco Nocini; Andrea Santarelli; Romina Rocchetti; Domenico Ciavarella; Lorenzo Lo Muzio; Francesca Fazioli
Journal:  BMC Cancer       Date:  2008-08-01       Impact factor: 4.430

7.  TNF-α-induced miR-450a mediates TMEM182 expression to promote oral squamous cell carcinoma motility.

Authors:  En-Wei Hsing; Shine-Gwo Shiah; Hsuan-Yu Peng; Ya-Wen Chen; Chih-Pin Chuu; Jenn-Ren Hsiao; Ping-Chiang Lyu; Jang-Yang Chang
Journal:  PLoS One       Date:  2019-03-20       Impact factor: 3.240

8.  Inhibition of Cell Proliferation and MAP Kinase and Akt Pathways in Oral Squamous cell Carcinoma by Genistein and Biochanin A.

Authors:  Tara L Johnson; Maria B Lai; James C K Lai; Alok Bhushan
Journal:  Evid Based Complement Alternat Med       Date:  2008-02-29       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.